Research teams from the Kaiser Permanente Division of Research and the University of Michigan have been granted a total of $10.5 million by the American Heart Association to investigate the application of artificial intelligence (AI) in improving cardiovascular disease care. This initiative underscores the potential of AI to revolutionize healthcare by enabling early detection and personalized treatment strategies for the leading cause of death in the U.S.

The Kaiser Permanente team, led by Dr. David Ouyang, will focus on utilizing AI to enhance the diagnostic capabilities of echocardiograms. These heart ultrasounds, which are cost-effective and radiation-free, may also reveal early signs of kidney and liver disease, conditions that exacerbate cardiovascular risks. The study aims to validate this approach across multiple healthcare systems, potentially leading to earlier interventions and better patient outcomes.

Meanwhile, the University of Michigan’s project, under Dr. Cindy Hsu’s leadership, seeks to refine CPR techniques through AI. By integrating a noninvasive wearable sensor with an AI algorithm, the team hopes to provide real-time feedback on blood flow during CPR, allowing for adjustments that could significantly improve survival rates from sudden cardiac arrest.

The significance of these projects is magnified by the rising global prevalence of cardiovascular, kidney, and liver diseases. With cardiovascular disease responsible for approximately 19.41 million deaths worldwide in 2021, and the increasing incidence of related conditions, the need for innovative solutions is urgent. The American Heart Association’s investment in these studies reflects a commitment to leveraging cutting-edge technology to address these challenges, building on its longstanding role as a leader in cardiovascular research and advocacy.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Research Teams Awarded $10.5 Million to Explore AI’s Role in Combating Cardiovascular Disease.